Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$496K Sell
2,910
-128
-4% -$23.5K 0.14% 137
2017
Q4
$528K Sell
3,038
-913
-23% -$162K 0.14% 132
2017
Q3
$737K Sell
3,951
-676
-15% -$120K 0.2% 110
2017
Q2
$797K Sell
4,627
-50
-1% -$8.13K 0.22% 105
2017
Q1
$767K Sell
4,677
-46
-1% -$7.64K 0.22% 106
2016
Q4
$690K Sell
4,723
-64
-1% -$9.63K 0.2% 109
2016
Q3
$798K Sell
4,787
-62
-1% -$10.5K 0.24% 98
2016
Q2
$738K Sell
4,849
-1
-0% -$155 0.23% 99
2016
Q1
$727K Sell
4,850
-32
-0.7% -$4.75K 0.23% 100
2015
Q4
$793K Buy
4,882
+2,178
+81% +$342K 0.26% 98
2015
Q3
$374K Buy
2,704
+120
+5% +$18.9K 0.42% 53
2015
Q2
$397K Buy
2,584
+320
+14% +$51.3K 0.39% 59
2015
Q1
$362K Buy
2,264
+85
+4% +$13.4K 0.36% 62
2014
Q4
$347K Buy
+2,179
New +$340K 0.31% 63

Other funds holding AMGN

Argent Trust's AMGN Position: Q1 2018 in Review

Argent Trust reduced its Amgen (AMGN) stake by 4.2% in Q1 2018, selling an estimated $23.5K and leaving 2,910 shares worth $496K. The position accounts for 0.14% of the portfolio, ranked #137.

Argent Trust first reported a position in AMGN in Q4 2014 and has held it in 14 quarters since. The position peaked at $798K in Q3 2016. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Argent Trust held 2,910 shares of Amgen worth $496K as of Q1 2018.
  • Argent Trust sold 128 Amgen shares in Q1 2018, an estimated $23.5K.
  • Amgen made up 0.14% of Argent Trust's portfolio in Q1 2018, its #137 holding.
  • Argent Trust first reported a position in Amgen in Q4 2014 and has held it in 14 quarters since.
  • Argent Trust's Amgen position peaked at $798K in Q3 2016.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.